Table 1 Baseline demographic and disease characteristics of a cohort (n = 206) of resectable GC and GEJ adenocarcinoma patients treated with perioperative FLOT in a real-world setting
From: Results of the observational prospective RealFLOT study
Patients N (%) | |
|---|---|
Sex | |
Male | 141 (68%) |
Female | 65 (32%) |
Age (y) | |
Median (range) | 63 (36–77) |
< 65 years | 117 (57%) |
≥ 65 years | 89 (43%) |
ECOG PS | |
0 | 189 (92%) |
1 | 17 (8%) |
Location | |
Stomach | 114 (55%) |
GEJ | 92 (45%) |
Lauren’s type | |
Intestinal | 37 (18%) |
Diffuse | 27 (13%) |
Mixed | 11 (5%) |
Not evaluable according to Lauren | 134 (64%) |
Signet ring cells | |
Yes | 31 (15%) |
Not specified | 175 (85%) |
cT | |
T1–2 | 26 (13%) |
T3–4 | 180 (87%) |
cN | |
N0 | 32 (16%) |
N1 | 61 (30%) |
N2 | 73 (35%) |
N3 | 40 (19%) |
Grading | |
G1 | 4 (2%) |
G2 | 16 (8%) |
G3 | 114 (55%) |
Missing | 72 (35%) |